ArticleInterventional pain medicine2026
Intra-articular sacroiliac joint steroid injection in patients with risk factors may have greater effect.
Article in Interventional pain medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Low back pain (LBP) is highly prevalent, with the sacroiliac joint (SIJ) implicated in up to ∼30 % of cases. Intra-articular steroid injections are an established treatment for SIJ pain. Several risk factors-including lumbosacral fusion, total hip arthroplasty, pelvic fracture, inflammatory bowel disease, and seronegative spondyloarthropathy-are known to predispose patients to SIJ pain. However, it remains unclear whether these preconditions predict treatment response. Objective: To determine whether the presence of known SIJ pain risk factors correlates with improved patient-reported outcomes following SIJ intra-articular steroid injection. Methods: A retrospective cohort study was conducted at the University of Rochester using electronic medical records from September 1, 2013 to February 1, 2023. Patients aged 18-95 years with SIJ pain who underwent fluoroscopic or ultrasound-guided SIJ injection and completed Patient Reported Outcome Measurement Information System (PROMIS) Pain Interference (PI) and/or Physical Function (PF) surveys before and after injection were included. Outcomes were compared between patients with and without preconditions. Statistical significance was set at p < 0.05. Cohen's d test was preformed to determine the effect of having a precondition. Results: Of 4780 patients identified, 91 completed PROMIS PI and 168 completed PROMIS PF surveys within the required timeframe. Among these, 27 (PI) and 40 (PF) had a precondition. The mean PI score change was 0.854 in the precondition group and 0.509 in the non-precondition group; PF score change was 1.30 and -0.378, respectively. Neither within-group changes nor between-group differences reached statistical significance (PI p = 0.739; PF p = 0.114). The effect size, measured by Cohen's d, of preconditions versus no preconditions, was d = 0.08 in the PI group, indicating little to no effect. The effect size, measured by Cohen's d, of preconditions versus no preconditions, was d = 0.28 in the PF group, indicating a small effect. Conclusion: The presence of established SIJ pain risk factors did not predict improved response to intra-articular steroid injection when using
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.